DRUG PRICING

Advertisement
Dec 20 2025HEALTH

Medicare Takes a Stand: New Plans to Cut Drug Costs

The U. S. government has rolled out two new plans to tackle high drug prices for seniors and people with disabilities. These plans, called GUARD and GLOBE, will start in 2026 and 2027. The goal is to make sure drug prices under Medicare are more like those in other countries with similar economies.

reading time less than a minute
Dec 02 2025HEALTH

Pharma Trade Pact: What's In It For The U. S. ?

A recent trade agreement between the U. S. and the U. K. has sparked discussions about job creation and pharmaceutical trade. The deal, which eliminates tariffs on U. K. medicines exported to the U. S. for three years, comes with a catch. In exchange, U. K. drug companies must invest more in the U.

reading time less than a minute
Nov 21 2025HEALTH

Mark Cuban's Bold Plan to Shake Up Healthcare

Mark Cuban has some strong opinions about healthcare. He recently spent nearly an hour talking about drug prices. This was supposed to be a short chat for a podcast. But Cuban had a lot to say. He's not holding back. Cuban wants to make big changes in healthcare. He's got ideas about how to make th

reading time less than a minute
Nov 07 2025HEALTH

Medicare to Cover Weight Loss Drugs: A $35 Billion Deal

A recent deal will allow Medicare to cover weight loss drugs, but it comes with a hefty price tag. The prices for drugs like Ozempic and Wegovy will drop significantly when bought through Medicare and Medicaid. Ozempic will cost $350 per month instead of $1, 000, and Wegovy will be $350 instead of $

reading time less than a minute
Nov 04 2025HEALTH

Big Pharma Makes a Deal: Cheaper Drugs for Medicare

Two major drug companies, Lilly and Novo Nordisk, are close to striking a deal with the White House. They want to offer their weight loss drugs at a lower price. This is big news because it could mean more people can afford these medicines. The plan is to sell the lowest dose of their obesity drugs

reading time less than a minute
Aug 07 2025POLITICS

Big Pharma Boss Joins Trump Fundraiser Amid Drug Price Fight

Albert Bourla, the CEO of Pfizer, is set to attend a high-profile fundraiser at President Trump's golf club in Bedminster, New Jersey. The event, organized to support the pro-Trump group MAGA Inc. , aims to raise a whopping $25 million. This comes just a day after Trump sent letters to major drug co

reading time less than a minute
Jul 08 2025POLITICS

Big Pharma Faces Potential 200% Tariff Shock

In a surprising move, President Donald Trump hinted at a massive 200% tariff on imported pharmaceuticals. This announcement came during a cabinet meeting, catching many off guard. The president mentioned that these tariffs could be implemented soon but gave a grace period of about a year and a half.

reading time less than a minute
Jun 24 2025CRYPTO

Drug Prices: A Bitcoin Perspective on Affordability

The U. S. Federal Reserve has been printing a lot of money lately. From 2019 to 2023, they added over $6. 3 trillion to the economy. This has made things more expensive, including prescription drugs. People without insurance or with low incomes are hit the hardest. Bitcoin is different. It has a fi

reading time less than a minute
May 13 2025POLITICS

Medicaid Cuts: The Battle Within the Republican Party

The Republican Party is pushing forward with a plan to reduce Medicaid spending by hundreds of billions of dollars. This move comes despite internal disagreements and a promise from former President Trump not to cut the program. The House Republicans are determined to advance key parts of their bill

reading time less than a minute
May 12 2025POLITICS

A New Plan to Lower Drug Prices: Will It Work?

The United States has long struggled with high drug prices, which are often two to three times higher than in other developed countries. This is why President Trump recently revived a policy aimed at reducing these costs. This policy, known as the "most favored nation" approach, ties the prices th

reading time less than a minute